Home/Filings/4/0001181431-05-039070
4//SEC Filing

HEMOSENSE INC 4

Accession 0001181431-05-039070

CIK 0001127393operating

Filed

Jul 5, 8:00 PM ET

Accepted

Jul 6, 6:30 PM ET

Size

12.8 KB

Accession

0001181431-05-039070

Insider Transaction Report

Form 4
Period: 2005-07-01
Transactions
  • Conversion

    Series A-3 Preferred Stock

    2005-07-01427,0660 total
    Common Stock (106,766 underlying)
  • Conversion

    Common Stock

    2005-07-01+138,412142,683 total
  • Conversion

    Series C-3 Preferred Stock

    2005-07-01126,5840 total
    Common Stock (31,646 underlying)
Transactions
  • Conversion

    Common Stock

    2005-07-01+138,412142,683 total
  • Conversion

    Series A-3 Preferred Stock

    2005-07-01427,0660 total
    Common Stock (106,766 underlying)
  • Conversion

    Series C-3 Preferred Stock

    2005-07-01126,5840 total
    Common Stock (31,646 underlying)
Footnotes (4)
  • [F1]Not applicable.
  • [F2]Each share of Series A-3 and C-3 Preferred Stock converted into Common Stock on a 1-for-4 basis immediately prior to the closing of the issuer's initial public offering.
  • [F3]Immediately.
  • [F4]The reported securities are owned directly by MGVF III, Ltd. and indirectly by Marc Geller, as Managing Director of MGVF III, Ltd. Mr. Geller disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

Issuer

HEMOSENSE INC

CIK 0001127393

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001127393

Filing Metadata

Form type
4
Filed
Jul 5, 8:00 PM ET
Accepted
Jul 6, 6:30 PM ET
Size
12.8 KB